British Medical Bulletin 46:423-441 (1990)
© 1990 The British Council
research-article |
Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis
Chiron Corporation, Emeryville California, USA
Centers for Disease Control, Atlanta Georgia, USA
Abstract
A ‘blind’ recombinant immunoscreening approach, of general application to studies of infectious diseases, was used to clone and identify the genome of the previouly uncharacterized non-A, non-B hepatitis (NANB) virus. This agent is a positive-stranded RNA virus that appears to be distantly related to the flaviviridae family. A recombinant viral antigen (C100-3) was used to develop a capature assay for circulation antibody. Data obtained using this assay indicate that this agent, termed the hepatitis C virus (HCV), is the major cause of post-transfusion, community-acquired and cryptogenic, NANB. Anti-C100-3 antibody appears to be directed towards dominant, non-structural viral epitopes. It is a non-neutralisting antibody that develops generally late in infection and is a particularly good marker of chronic, persistent viraemia. Many asymptomatic but infectious blood donors can now be detected using the antibody assay. HCV isassociated with the development of hepatocellular carcinoma and possibly, other liver diseases.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Sikora, Y. Chen, C. F. Lichti, M. K. Harrison, T. A. Jennings, Y. Tang, A. J. Tackett, J. B. Jordan, J. Sakon, C. E. Cameron, et al. Hepatitis C Virus NS3 Helicase Forms Oligomeric Structures That Exhibit Optimal DNA Unwinding Activity in Vitro J. Biol. Chem., April 25, 2008; 283(17): 11516 - 11525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qin, N. J. Shire, E. D. Keenan, S. D. Rouster, M. E. Eyster, J. J. Goedert, M. J. Koziel, K. E. Sherman, and and the Multicenter Hemophilia Cohort Study Group HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV Blood, January 15, 2005; 105(2): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Henderson Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting Clin. Microbiol. Rev., July 1, 2003; 16(3): 546 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. M. Wang, M. A. Hockman, K. Staschke, R. B. Johnson, K. A. Case, J. Lu, S. Parsons, F. Zhang, R. Rathnachalam, K. Kirkegaard, et al. Oligomerization and Cooperative RNA Synthesis Activity of Hepatitis C Virus RNA-Dependent RNA Polymerase J. Virol., March 19, 2002; 76(8): 3865 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brinster, M. Chen, D. Boucreux, G. Paranhos-Baccala, P. Liljestrom, F. Lemmonier, and G. Inchauspe Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles J. Gen. Virol., February 1, 2002; 83(2): 369 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Weiner, X. Paliard, M. J. Selby, A. Medina-Selby, D. Coit, S. Nguyen, J. Kansopon, C. L. Arian, P. Ng, J. Tucker, et al. Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity J. Virol., August 1, 2001; 75(15): 7142 - 7148. [Abstract] [Full Text]
|
|
|
|
 |
|
 J C L Booth, J O'Grady, and J Neuberger Clinical guidelines on the management of hepatitis C Gut, July 1, 2001; 49(0): I1 - 21. [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Kessler, E. Stelzl, R. B. Raggam, J. Haas, F. Kirchmeir, K. Hegenbarth, E. Daghofer, B. I. Santner, E. Marth, and R. E. Stauber Effects of Storage and Type of Blood Collection Tubes on Hepatitis C Virus Level in Whole Blood Samples J. Clin. Microbiol., May 1, 2001; 39(5): 1788 - 1790. [Abstract] [Full Text]
|
|
|
|
|
|
A. Meola, A. Sbardellati, B. Bruni ercole, M. Cerretani, M. Pezzanera, A. Ceccacci, A. Vitelli, S. Levy, A. Nicosia, C. Traboni, et al. Binding of Hepatitis C Virus E2 Glycoprotein to CD81 Does Not Correlate with Species Permissiveness to Infection J. Virol., July 1, 2000; 74(13): 5933 - 5938. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. V. Chisari Viruses, Immunity, and Cancer: Lessons from Hepatitis B Am. J. Pathol., April 1, 2000; 156(4): 1117 - 1132. [Full Text] [PDF]
|
|
|
|
|
|
V. Barban, S. Fraysse-Corgier, G. Paranhos-Baccala, M. Petit, C. Manin, Y. Berard, A. M. Prince, B. Mandrand, and P. Meulien Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient J. Gen. Virol., February 1, 2000; 81(2): 461 - 469. [Abstract] [Full Text]
|
|
|
|
 |
|
 R Perniola, C De Rinaldis, E Accogli, and G Lobreglio Prevalence and clinical features of cryoglobulinaemia in multitransfused beta -thalassaemia patients Ann Rheum Dis, November 1, 1999; 58(11): 698 - 702. [Abstract] [Full Text]
|
|
|
|
|
|
P. Borowski, J. S. zur Wiesch, K. Resch, H. Feucht, R. Laufs, and H. Schmitz Protein Kinase C Recognizes the Protein Kinase A-binding Motif of Nonstructural Protein 3 of Hepatitis C Virus J. Biol. Chem., October 22, 1999; 274(43): 30722 - 30728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Scognamiglio, D. Accapezzato, M. A. Casciaro, A. Cacciani, M. Artini, G. Bruno, M. L. Chircu, J. Sidney, S. Southwood, S. Abrignani, et al. Presence of Effector CD8+ T Cells in Hepatitis C Virus-Exposed Healthy Seronegative Donors J. Immunol., June 1, 1999; 162(11): 6681 - 6689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sansonno, S. De Vita, A. R. Iacobelli, V. Cornacchiulo, M. Boiocchi, and F. Dammacco Clonal Analysis of Intrahepatic B Cells from HCV-Infected Patients With and Without Mixed Cryoglobulinemia J. Immunol., April 1, 1998; 160(7): 3594 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Lai, A M Prince, L Wolfe, and L Andrus A simplified method for PCR detection of hepatitis C virus RNA from human serum. Genome Res., April 1, 1994; 3(5): 308 - 309. [PDF]
|
|
|
|
|
|
A Ravaggi, D Primi, and E Cariani Direct PCR amplification of HCV RNA from human serum. Genome Res., May 1, 1992; 1(4): 291 - 292. [PDF]
|
|